US Bancorp DE trimmed its stake in shares of MaxLinear, Inc. (NASDAQ:MXL - Free Report) by 86.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,920 shares of the semiconductor company's stock after selling 24,688 shares during the quarter. US Bancorp DE's holdings in MaxLinear were worth $78,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of MXL. Pacer Advisors Inc. boosted its holdings in shares of MaxLinear by 29.0% during the fourth quarter. Pacer Advisors Inc. now owns 1,968 shares of the semiconductor company's stock worth $39,000 after purchasing an additional 443 shares during the period. Truvestments Capital LLC bought a new position in MaxLinear during the 3rd quarter valued at approximately $42,000. R Squared Ltd purchased a new stake in MaxLinear in the 4th quarter worth approximately $45,000. GAMMA Investing LLC grew its position in shares of MaxLinear by 19.1% in the 4th quarter. GAMMA Investing LLC now owns 4,134 shares of the semiconductor company's stock worth $82,000 after buying an additional 662 shares during the last quarter. Finally, Captrust Financial Advisors purchased a new position in shares of MaxLinear during the third quarter valued at approximately $159,000. 90.79% of the stock is owned by hedge funds and other institutional investors.
MaxLinear Stock Performance
NASDAQ:MXL traded down $0.28 during mid-day trading on Friday, reaching $12.70. The company's stock had a trading volume of 899,735 shares, compared to its average volume of 1,281,689. The firm's fifty day moving average price is $17.14 and its two-hundred day moving average price is $16.39. The company has a current ratio of 1.77, a quick ratio of 1.28 and a debt-to-equity ratio of 0.24. The stock has a market cap of $1.07 billion, a P/E ratio of -4.33 and a beta of 1.76. MaxLinear, Inc. has a 12-month low of $11.08 and a 12-month high of $26.59.
MaxLinear (NASDAQ:MXL - Get Free Report) last issued its earnings results on Wednesday, January 29th. The semiconductor company reported ($0.27) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.13) by ($0.14). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. On average, equities analysts forecast that MaxLinear, Inc. will post -0.37 EPS for the current fiscal year.
Analyst Ratings Changes
A number of analysts recently commented on MXL shares. Benchmark reaffirmed a "buy" rating and issued a $28.00 price target on shares of MaxLinear in a research note on Thursday, January 30th. Wells Fargo & Company lifted their target price on shares of MaxLinear from $19.00 to $20.00 and gave the company an "equal weight" rating in a research note on Thursday, January 30th. Northland Securities increased their price target on shares of MaxLinear from $25.00 to $27.50 and gave the stock an "outperform" rating in a research note on Monday, January 6th. Needham & Company LLC restated a "hold" rating on shares of MaxLinear in a report on Thursday, January 30th. Finally, Susquehanna reduced their target price on MaxLinear from $25.00 to $23.00 and set a "neutral" rating on the stock in a report on Thursday, January 30th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, MaxLinear has a consensus rating of "Hold" and a consensus price target of $25.50.
Check Out Our Latest Stock Analysis on MaxLinear
MaxLinear Profile
(
Free Report)
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Recommended Stories

Before you consider MaxLinear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.
While MaxLinear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.